Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · IEX Real-Time Price · USD
17.22
+0.12 (0.70%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Entrada Therapeutics Market Cap
Entrada Therapeutics has a market cap or net worth of $639.31 million as of July 26, 2024. Its market cap has increased by 22.05% in one year.
Market Cap
639.31M
Enterprise Value
374.38M
1-Year Change
22.05%
Ranking
Category
Stock Price
$17.22
Market Cap Chart
Since the IPO on October 29, 2021, Entrada Therapeutics's market cap has increased from $597.75M to $639.31M, an increase of 6.95%. That is a compound annual growth rate of 2.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 577.30M | 14.66% |
| Dec 29, 2023 | 503.50M | 18.58% |
| Dec 30, 2022 | 424.60M | -20.55% |
| Dec 31, 2021 | 534.40M | -10.60% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allogene Therapeutics | 607.56M |
| Larimar Therapeutics | 605.48M |
| Arcturus Therapeutics Holdings | 602.73M |
| Community Health Systems | 601.72M |
| LENZ Therapeutics | 601.08M |
| ProKidney | 599.39M |
| Applied Therapeutics | 598.76M |
| Avid Bioservices | 597.03M |